Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion

Journal of Lipid Research

Volumn 52, Issue 2, 2011, Pages 237-244

  Blade, Anna M ^a   Fabritius, Melissa A ^a   Hou, Li ^a   Weinberg, Richard B ^a   Shelness, Gregory S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein B; Lipid trafficking; Lipoprotein assembly

Indexed keywords

APOLIPOPROTEIN A5; FAT DROPLET; OLEIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; BIOGENESIS; CELL LEVEL; CHO CELL; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HEPATOMA CELL; LIPOGENESIS; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN TRANSPORT; RAT;

ANIMALS; APOLIPOPROTEINS; CHO CELLS; CRICETINAE; CRICETULUS; LIPOPROTEINS, VLDL; LIVER NEOPLASMS, EXPERIMENTAL; OLEIC ACID; RATS; TRANSFECTION; TRIGLYCERIDES;

EID: 78751510143     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M010793     Document Type: Article

References (53)

1. Forte, T. M., X. Shu, and R. O. Ryan. 2009. The ins (cell) and outs (plasma) of apolipoprotein A-V. J. Lipid Res. 50: S150-S155.
2. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173.
3. Schaap, F. G., P. C. N. Rensen, P. J. Voshol, C. Vrins, H. N. Van der Vliet, R. Chamuleau, L. M. Havekes, A. K. Groen, and K. W. Van Dijk. 2004. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279: 27941-27947.
4. Fruchart-Najib, J., E. Baugé, L. S. Niculescu, T. Pham, B. Thomas, C. Rommens, Z. Majd, B. Brewer, L. A. Pennacchio, and J. C. Fruchart. 2004. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem. Biophys. Res. Commun. 319: 397-404.
5. Merkel, M., B. Loeffler, M. Kluger, N. Fabig, G. Geppert, L. A. Pennacchio, A. Laatsch, and J. Heeren. 2005. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J. Biol. Chem. 280: 21553-21560.
6. Lookene, A., J. A. Beckstead, S. Nilsson, G. Olivecrona, and R. O. Ryan. 2005. Apolipoprotein A-V-heparin Interactions: implications for plasma lipoprotein metabolism. J. Biol. Chem. 280: 25383-25387.
7. Talmud, P. J. 2007. Rare APOA5 mutations-Clinical consequences, metabolic and functional effects: An ENID review. Atherosclerosis. 194: 287-292.
8. Nilsson, S. K., A. Lookene, J. A. Beckstead, J. Gliemann, R. O. Ryan, and G. Olivecrona. 2007. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry. 46: 3896-3904.
9. Dichlberger, A., L. A. Cogburn, J. Nimpf, and W. J. Schneider. 2007. Avian apolipoprotein A-V binds to LDL receptor gene family members. J. Lipid Res. 48: 1451-1456.
10. Nilsson, S. K., S. Christensen, M. K. Raarup, R. O. Ryan, M. S. Nielsen, and G. Olivecrona. 2008. Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the Vps10p domain receptor families. J. Biol. Chem. 283: 25920-25927.
11. Beigneux, A. P., B. S. Davies, P. Gin, M. M. Weinstein, E. Farber, X. Qiao, F. Peale, S. Bunting, R. L. Walzem, J. S. Wong, et al. 2007. Glycosylphosphatidylinositol-anchored high-density lipoproteinbinding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5: 279-291.
12. Priore Oliva, C., L. Pisciotta, G. L. Volti, M. P. Sambataro, A. Cantafora, A. Bellocchio, A. Catapano, P. Tarugi, S. Bertolini, and S. Calandra. 2005. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 25: 411-417.
13. Marçais, C., B. Verges, S. Charrière, V. Pruneta, M. Merlin, S. Billon, L. Perrot, J. Drai, A. Sassolas, L. A. Pennacchio, et al. 2005. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest. 115: 2862-2869.
14. Jakel, H., M. Nowak, A. Helleboid-Chapman, J. Fruchart-Najib, and J-C. Fruchart. 2006. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann. Med. 38: 2-10. (Pubitemid 43177782)
15. Kluger, M., J. Heeren, and M. Merkel. 2008. Apoprotein A-V: An important regulator of triglyceride metabolism. J. Inherit. Metab. Dis. 31: 281-288.
16. Nelbach, L., X. Shu, R. J. Konrad, R. O. Ryan, and T. M. Forte. 2008. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice. J. Lipid Res. 49: 572-580.
17. Vaessen, S. F. C., G. M. Dallinga-Thie, C. J. D. Ross, L. J. Splint, L. W. Castellani, P. C. N. Rensen, M. R. Hayden, F. G. Schaap, and J. A. Kuivenhoven. 2009. Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels. J. Lipid Res. 50: 880-884.
18. Assmann, G. 1982. Lipid metabolism and atherosclerosis. FK Schattauer Verlag GmbH, Stuttgart, Germany.
19. Olofsson, S. O. 2005. ApoA-V - The regulation of a regulator of plasma triglycerides. Arterioscler. Thromb. Vasc. Biol. 25: 1097-1099. (Pubitemid 40776593)
20. Weinberg, R. B., V. R. Cook, J. A. Beckstead, D. D. Martin, J. W. Gallagher, G. S. Shelness, and R. O. Ryan. 2003. Structure and interfacial properties of human apolipoprotein A-V. J. Biol. Chem. 278: 34438-34444.
21. van der Vliet, H. N., M. G. Sammels, A. C. Leegwater, J. H. Levels, P. H. Reitsma, W. Boers, and R. A. Chamuleau. 2001. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276: 44512-44520.
22. Qu, S., G. Perdomo, D. Su, F. M. D'Souza, N. S. Shachter, and H. H. Dong. 2007. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice. J. Lipid Res. 48: 1476-1487.
23. Shu, X., J. Chan, R. O. Ryan, and T. M. Forte. 2007. Apolipoprotein A-V association with intracellular lipid droplets. J. Lipid Res. 48: 1445-1450.
24. Shu, X., R. O. Ryan, and T. M. Forte. 2008. Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment. J. Lipid Res. 49: 1670-1676.
25. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1: 327-341.
26. Shelness, G. S., and J. T. Thornburg. 1996. Role of intramolecular disulfide bond formation in the assembly and secretion of apolipoprotein B-100-containing lipoproteins. J. Lipid Res. 37: 408-419.
27. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
28. Sellers, J. A., L. Hou, H. Athar, M. M. Hussain, and G. S. Shelness. 2003. A Drosophila microsomal triglyceride transfer protein homolog promotes the assembly and secretion of human apolipoprotein B - implications for human and insect lipid transport and metabolism. J. Biol. Chem. 278: 20367-20373.
29. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
30. Wang, Y., K. Tran, and Z. Yao. 1999. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within the microsomes in McA-RH7777 cells. J. Biol. Chem. 274: 27793-27800.
31. Chung, S., A. K. Gebre, J. Seo, G. S. Shelness, and J. S. Parks. 2010. A novel role for ABCA1-generated large pre-β migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion. J. Lipid Res. 51: 729-742.
32. Shu, X., L. Nelbach, R. O. Ryan, and T. M. Forte. 2010. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation. Biochim. Biophys. Acta. 1801: 605-608.
33. Shteyer, E., Y. Liao, L. J. Muglia, P. W. Hruz, and D. A. Rudnick. 2004. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology. 40: 1322-1332.
34. Fernandez, M. A., C. Albor, M. Ingelmo-Torres, S. J. Nixon, C. Ferguson, T. Kurzchalia, F. Tebar, C. Enrich, R. G. Parton, and A. Pol. 2006. Caveolin-1 is essential for liver regeneration. Science. 313: 1628-1632.
35. Brasaemle, D. L. 2006. A metabolic push to proliferate. Science. 313: 1581-1582.
36. Farrell, G. C. 2004. Probing Prometheus: fat fueling the fire? Hepatology. 40: 1252-1255.
37. Ploegh, H. L. 2007. A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum. Nature. 448: 435-438.
38. Brasaemle, D. L., T. Barber, N. Wolins, G. Serrero, E. Blanchette-Mackie, and C. Londos. 1997. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res. 38: 2249-2263.
39. Brasaemle, D. L., and N. E. Wolins. 2006. Isolation of lipid droplets from cells by density gradient centrifugation. In Current Protocols in Cell Biology. J. S. Bonifacino, M. Dasso, J. B. Harford, J. Lippincott-Schwartz, and K. M. Yamada, editors. John Wiley & Sons Inc., NY. 3.15.11-13.15.12.
40. Wong-Mauldin, K., V. Raussens, T. M. Forte, and R. O. Ryan. 2009. Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants. J. Biol. Chem. 284: 33369-33376.
41. Bagola, K., M. Mehnert, E. Jarosch, and T. Sommer. 2010. Protein dislocation from the ER. Biochim. Biophys. Acta. In press.
42. Martin, S., and R. G. Parton. 2006. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 7: 373-378.
43. Tijburg, L. B., C. B. Nyathi, G. W. Meijer, and M. J. Geelen. 1991. Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy. Biochem. J. 277: 723-728.
44. Grosskopf, I., N. Baroukh, S. J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper. 2005. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler. Thromb. Vasc. Biol. 25: 2573-2579.
45. Pamir, N., T. S. McMillen, Y-I. Li, C-M. Lai, H. Wong, and R. C. LeBoeuf. 2009. Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis. Metabolism. 58: 560-567.
46. Werner, A., R. Havinga, T. Bos, V. W. Bloks, F. Kuipers, and H. J. Verkade. 2005. Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G1150-G1158.
47. Huang, X-s., S-P. Zhao, M. Hu, L. Bai, Q. Zhang, and W. Zhao. 2010. Decreased apolipoprotein A5 is implicated in insulin resistancerelated hypertriglyceridemia in obesity. Atherosclerosis. 210: 563-568.
48. Jakel, H., M. Nowak, M. Moitrot, H. Dehondt, D. W. Hum, L. A. Pennacchio, J. Fruchart-Najib, and J. C. Fruchart. 2004. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J. Biol. Chem. 279: 45462-45469.
49. Browning, J. D., and J. D. Horton. 2004. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114: 147-152.
50. Goldberg, I. J., and H. N. Ginsberg. 2006. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology. 130: 1343-1346.
51. Prieur, X., F. G. Schaap, H. Coste, and J. C. Rodríguez. 2005. Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kinase, and mitogen-activated protein kinase pathway. Mol. Endocrinol. 19: 3107-3125.
52. Prieur, X., P. Lesnik, M. Moreau, J. C. RodrÌguez, C. Doucet, M. J. Chapman, and T. Huby. 2009. Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha: Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice. Biochim. Biophys. Acta.. 1791: 764-771.
53. Listenberger, L. L., X. Han, S. E. Lewis, S. Cases, R. V. Farese, Jr., D. S. Ory, and J. E. Schaffer. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA. 100: 3077-3082.